✦ LIBER ✦

Pegfilgrastim compared with filgrastim after high-dose melphalan and autologous hematopoietic peripheral blood stem cell transplantation in multiple myeloma patients

✍ Scribed by Massimo Martino; Giulia Praticò; Giuseppe Messina; Giuseppe Irrera; Elisabetta Massara; Giuseppe Messina; Giuseppe Console; Pasquale Iacopino

Book ID: 114794088
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 139 KB
Volume: 77
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2006.00736.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegfilgrastim compared with Filgrastim a

Pegfilgrastim compared with Filgrastim after autologous hematopoietic peripheral blood stem cell transplantation

✍ Gaëtan Vanstraelen; Pascale Frère; Marie-Christine Ngirabacu; Evelyne Willems; G 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Pegfilgrastim versus filgrastim to accel

Pegfilgrastim versus filgrastim to accelerate hematopoietic recovery after high-dose melphalan and autologous hematopoietic stem cell transplantation (ASCT) for multiple myeloma

✍ R.L. Olin; S.M. Luger; D.L. Porter; S.J. Schuster; D. Tsai; S. Nasta; A. Perl; A 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Pegfilgrastim compared with filgrastim a

Pegfilgrastim compared with filgrastim after autologous peripheral blood stem cell transplantation in patients with solid tumours and lymphomas

✍ Alberto Ballestrero; Davide Boy; Roberta Gonella; Maurizio Miglino; Marino Clavi 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 137 KB

PCN60 COST-EFFECTIVENESS OF PEGFILGRASTI

PCN60 COST-EFFECTIVENESS OF PEGFILGRASTIM VERSUS FILGRASTIM AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH LYMPHOMA AND MYELOMA

✍ L. Perrier; A. Lefranc; P. Quittet; P. Moreau; C. Siani; H. Ghesquières; F. Jard 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

High-dose chemotherapy and autologous pe

High-dose chemotherapy and autologous peripheral blood stem cell transplantation in high-risk multiple myeloma

✍ Hirokazu Murakami; Hiroshi Fujii; Tohru Inaba; Chihiro Shimazaki; Sinichirou Oka 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

Comparison of fixed dose pegfilgrastim a

Comparison of fixed dose pegfilgrastim and daily filgrastim after autologous stem cell transplantation in patients with multiple myeloma autografted on a outpatient basis

✍ Felicetto Ferrara; Tiziana Izzo; Clelia Criscuolo; Cira Riccardi; Assunta Viola; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

## Abstract Different authors have explored the feasibility of autografting patients with multiple myeloma (MM) on an outpatient basis. Peg‐filgrastim (PEG), a long‐acting recombinant G‐CSF, has similar efficacy when compared to conventional G‐CSF for chemotherapy‐induced neutropenia, but little is